<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="1528" OLDID="17946" TOPICS="YES">
<DATE> 4-MAR-1987 11:09:08.66</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0571 reute
d f BC-ELECTRO-NUCLEONICS-IN   03-04 0092</UNKNOWN>
<TEXT> 
<TITLE>ELECTRO-NUCLEONICS INC &lt;ENUC&gt; 2ND QTR DEC 31</TITLE>
<DATELINE>    FAIRFIELD, N.J., March 4 -
    </DATELINE><BODY>Shr loss 1.77 dlrs vs profit 15 cts
    Net loss 8,036,000 vs profit 576,000
    Sales 16.2 mln vs 17.2 mln
    Avg shrs 4,539,437 vs 3,816,580
    1st half
    Shr loss 1.96 dlrs vs profit 26 cts
    Net loss 8,231,000 vs profit 996,000
    Sales 30.9 mln vs 32.2 mln
    Avg shrs 4,205,707 vs 3,814,141
    NOTE: Current half net includes 68,000 dlr tax credit.
    Current year net both periods includes 6,700,000 dlr
writedown of inventory of clinical chemistry products.
 Reuter
 </BODY></TEXT>
</REUTERS>